Author: Edison Ong; Mei U Wong; Anthony Huffman; Yongqun He
Title: COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning Document date: 2020_3_21
ID: ld0vo1rl_9
Snippet: The multiple sequence alignment and the resulting phylogeny of nsp3 protein showed that 174 this protein in SARS-CoV-2 was more closely related to the human coronaviruses SARS-CoV and 175 MERS-CoV, and bat coronaviruses BtCoV/HKU3, BtCoV/HKU4, and BtCoV/HKU9. We studied 176 the genetic conservation of nsp3 protein ( Figure 1A (Table S4 -5). In terms of linear B cell epitopes, there were 14 epitopes with BepiPred 195 scores over 0.55 and had at le.....
Document: The multiple sequence alignment and the resulting phylogeny of nsp3 protein showed that 174 this protein in SARS-CoV-2 was more closely related to the human coronaviruses SARS-CoV and 175 MERS-CoV, and bat coronaviruses BtCoV/HKU3, BtCoV/HKU4, and BtCoV/HKU9. We studied 176 the genetic conservation of nsp3 protein ( Figure 1A (Table S4 -5). In terms of linear B cell epitopes, there were 14 epitopes with BepiPred 195 scores over 0.55 and had at least ten amino acids in length (Table S6) (Table 2 ). But the inactivated or attenuated whole virus vaccine might induce strong 218 adverse events. On the other hand, vaccines targeting the structural proteins induce a strong 219 immune response 23,32,33 . In some studies, these structural proteins, including the S and N proteins, 220 were reported to associate with the pathogenesis of coronavirus 24,34 and might raise safety 221 concern 11 . Our study applied state-of-the-art Vaxign reserve vaccinology (RV) and Vaxign-ML 222 only the S protein may induce high serum-neutralizing antibody titers but cannot induce complete 231 protection 10 . In addition, HCoV-NL63 also uses S protein and employs the angiotensin-converting 232 enzyme 2 (ACE2) for cellular entry, despite markedly weak pathogenicity 35 . This suggests that the 233 S protein is not the only factor determining the infection level of a human coronavirus. Thus, 234 alternative vaccine antigens may be considered as potential targets for COVID-19 vaccines. 235
Search related documents:
Co phrase search for related documents- adverse event and amino acid: 1
- adverse event and antibody titer: 1, 2, 3
- adverse event and art state: 1, 2
- adverse event and human coronavirus: 1
- adverse event and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- alternative vaccine and amino acid: 1
- alternative vaccine and art state: 1
- alternative vaccine and cell epitope: 1, 2
- alternative vaccine and human coronavirus: 1, 2
- alternative vaccine and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- amino acid and antibody titer: 1, 2, 3, 4, 5
- amino acid and art state: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- amino acid and cell epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and cellular entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and coronavirus pathogenesis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amino acid and genetic conservation: 1
- amino acid and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- angiotensin convert and cellular entry: 1
Co phrase search for related documents, hyperlinks ordered by date